Adcentrx Therapeutics
3 known investors
Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.
BiotechHealthtech
Founders & leadership
HL
Hui LiinPresident & CEO
Investors · 3
Competitors · 2
by search overlapAddex Therapeutics18 shared keywordsAddex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.
Bioworld17 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Adcentrx Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adcentrx Therapeutics do?
- Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.
- Who are Adcentrx Therapeutics's investors?
- Adcentrx Therapeutics's investors include Eight Roads Ventures, F-Prime Capital, Quan Capital.